We are live on ! Find out more
FP

Foundry Partners Portfolio holdings

AUM $1.89B
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.44B
AUM Growth
+$40.3M
Cap. Flow
+$4.35M
Cap. Flow %
0.18%
Top 10 Hldgs %
10.18%
Holding
465
New
32
Increased
211
Reduced
164
Closed
58

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$15.3M
2
CSCO icon
Cisco
CSCO
+$13M
3
BMY icon
Bristol-Myers Squibb
BMY
+$12.4M
4
CCL icon
Carnival Corporation Ltd
CCL
+$12M
5
TGT icon
Target
TGT
+$11.7M

Sector Composition

Rank Sector Weight
1 Financials 25.59%
2 Industrials 16.5%
3 Technology 12.91%
4 Healthcare 9.55%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
METC icon
301
Ramaco Resources Class A
METC
$793M
$2.12M 0.09%
+361,473
New +$2.35M
CDOR
302
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$2.11M 0.09%
197,025
+67,000
+52% +$702K
SIFI
303
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$2.1M 0.09%
130,571
-2,900
-2% -$43.7K
MLNX
304
DELISTED
Mellanox Technologies, Ltd.
MLNX
$2.09M 0.09%
48,304
-2,717
-5% -$129K
HUBG icon
305
HUB Group
HUBG
$3.11B
$2.08M 0.09%
108,668
-43,218
-28% -$824K
KNL
306
DELISTED
Knoll, Inc.
KNL
$2.07M 0.08%
103,076
-41,826
-29% -$941K
CPS icon
307
Cooper-Standard Automotive
CPS
$510M
$2.04M 0.08%
20,177
-4,259
-17% -$456K
AMCX icon
308
AMC Global Media
AMCX
$441M
$2.01M 0.08%
+37,590
New +$2.1M
MIDD icon
309
Middleby
MIDD
$5.92B
$2.01M 0.08%
16,507
-11,320
-41% -$1.5M
BELFB
310
Bel Fuse Inc Class B
BELFB
$4.02B
$1.92M 0.08%
+77,853
New +$1.87M
UTL icon
311
Unitil
UTL
$992M
$1.91M 0.08%
+39,623
New +$1.88M
BPMC
312
DELISTED
Blueprint Medicines
BPMC
$1.86M 0.08%
36,687
-844
-2% -$35.8K
BOCH
313
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$1.8M 0.07%
163,130
-22,900
-12% -$254K
HBIO icon
314
Harvard Bioscience
HBIO
$27.4M
$1.75M 0.07%
68,478
+1,858
+3% +$46K
NRIM icon
315
Northrim BanCorp
NRIM
$611M
$1.74M 0.07%
228,860
-3,800
-2% -$29.2K
INVA icon
316
Innoviva
INVA
$1.57B
$1.73M 0.07%
135,231
-3,108
-2% -$39K
CNTY icon
317
Century Casinos
CNTY
$33.8M
$1.67M 0.07%
226,055
-3,500
-2% -$27.5K
GNBC
318
DELISTED
Green Bancorp, Inc
GNBC
$1.65M 0.07%
85,250
-27,350
-24% -$505K
CTRN icon
319
Citi Trends
CTRN
$539M
$1.63M 0.07%
76,766
-1,764
-2% -$33.3K
CCUR
320
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
$1.48M 0.06%
222,840
-3,450
-2% -$20.4K
DNR
321
DELISTED
Denbury Resources, Inc.
DNR
$1.45M 0.06%
950,053
+68,953
+8% +$129K
CULP icon
322
Culp Inc
CULP
$46.6M
$1.45M 0.06%
44,720
-14,150
-24% -$457K
NBN icon
323
Northeast Bank
NBN
$1.1B
$1.45M 0.06%
71,400
-24,675
-26% -$451K
KDNY
324
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.27M 0.05%
22,213
-502
-2% -$25.2K
CTMX icon
325
CytomX Therapeutics
CTMX
$738M
$1.19M 0.05%
+76,498
New +$1.15M

Similar funds

Foundry Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Foundry Partners held 465 positions worth $2.44B, up 1.7% from $2.4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Foundry Partners's Q2 2017 filing shows 32 new, 211 increased, 164 reduced and 58 closed positions. Its largest new stake was Oracle: 335,485 shares worth $16.8M. The largest sale was Intel, an estimated $20.2M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Technology.

  • Foundry Partners's largest Q2 2017 buy was Oracle: 335,485 shares worth $16.8M.
  • Foundry Partners added most to Bristol-Myers Squibb in Q2 2017, an estimated $12.4M increase.
  • Foundry Partners's biggest Q2 2017 reduction was Intel, cutting an estimated $20.2M.
  • Foundry Partners fully exited Travelers Companies in Q2 2017, selling an estimated $16.4M.
  • Foundry Partners's ten largest holdings make up 10% of its $2.44B portfolio in Q2 2017.
  • Foundry Partners opened 32 new positions and closed 58 in Q2 2017.
  • Foundry Partners's portfolio value rose 1.7% quarter-over-quarter to $2.44B.

Based on Foundry Partners's 13F filing for Q2 2017, filed 2 Aug 2017.